The clinical significance of presented data consists in their potent impact on optimization of HCC treatment since the VEGFA isoforms ratio may be a promising factor for prediction of anti-angiogenic therapy efficiency. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.